2D miR_HR1_12
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Irf2
|
ENSMUSG00000031627.7 | interferon regulatory factor 2 |
Irf1
|
ENSMUSG00000018899.10 | interferon regulatory factor 1 |
Irf8
|
ENSMUSG00000041515.3 | interferon regulatory factor 8 |
Irf9
|
ENSMUSG00000002325.8 | interferon regulatory factor 9 |
Irf7
|
ENSMUSG00000025498.8 | interferon regulatory factor 7 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Irf2 | mm10_v2_chr8_+_46739745_46739791 | -0.52 | 8.2e-02 | Click! |
Irf1 | mm10_v2_chr11_+_53770458_53770509 | 0.45 | 1.4e-01 | Click! |
Irf8 | mm10_v2_chr8_+_120736352_120736385 | -0.43 | 1.6e-01 | Click! |
Irf7 | mm10_v2_chr7_-_141266415_141266481 | 0.33 | 3.0e-01 | Click! |
Irf9 | mm10_v2_chr14_+_55604550_55604579 | -0.15 | 6.5e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr7_+_104244449 | 5.03 |
ENSMUST00000106849.2
ENSMUST00000060315.5 |
Trim34a
|
tripartite motif-containing 34A |
chr8_+_61928081 | 3.75 |
ENSMUST00000154398.1
ENSMUST00000093485.2 ENSMUST00000156980.1 ENSMUST00000070631.7 |
Ddx60
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 60 |
chr3_+_142620596 | 3.36 |
ENSMUST00000165774.1
|
Gbp2
|
guanylate binding protein 2 |
chr3_-_113574242 | 3.33 |
ENSMUST00000142505.2
|
Amy1
|
amylase 1, salivary |
chr7_+_104244465 | 3.24 |
ENSMUST00000106848.1
|
Trim34a
|
tripartite motif-containing 34A |
chr3_-_113574758 | 3.00 |
ENSMUST00000106540.1
|
Amy1
|
amylase 1, salivary |
chr19_+_34640871 | 2.97 |
ENSMUST00000102824.3
|
Ifit1
|
interferon-induced protein with tetratricopeptide repeats 1 |
chr16_+_23609895 | 2.83 |
ENSMUST00000038423.5
|
Rtp4
|
receptor transporter protein 4 |
chr12_-_79007276 | 2.53 |
ENSMUST00000056660.6
ENSMUST00000174721.1 |
Tmem229b
|
transmembrane protein 229B |
chr8_-_105938384 | 2.52 |
ENSMUST00000034369.8
|
Psmb10
|
proteasome (prosome, macropain) subunit, beta type 10 |
chr4_-_40239700 | 2.49 |
ENSMUST00000142055.1
|
Ddx58
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 58 |
chr17_+_33919332 | 2.10 |
ENSMUST00000025161.7
|
Tapbp
|
TAP binding protein |
chr8_+_64947177 | 2.05 |
ENSMUST00000079896.7
ENSMUST00000026595.5 |
Tmem192
|
transmembrane protein 192 |
chr15_+_9436028 | 2.04 |
ENSMUST00000042360.3
|
Capsl
|
calcyphosine-like |
chr7_-_102565425 | 2.02 |
ENSMUST00000106913.1
ENSMUST00000033264.4 |
Trim21
|
tripartite motif-containing 21 |
chr4_-_40239779 | 1.98 |
ENSMUST00000037907.6
|
Ddx58
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 58 |
chr7_+_104244496 | 1.96 |
ENSMUST00000106854.1
ENSMUST00000143414.1 |
Trim34a
|
tripartite motif-containing 34A |
chr1_+_153751859 | 1.92 |
ENSMUST00000182538.1
|
Rnasel
|
ribonuclease L (2', 5'-oligoisoadenylate synthetase-dependent) |
chr11_-_53859187 | 1.74 |
ENSMUST00000117316.1
ENSMUST00000120776.1 ENSMUST00000121435.1 |
Gm12216
|
predicted gene 12216 |
chr7_-_141266415 | 1.69 |
ENSMUST00000106023.1
ENSMUST00000097952.2 ENSMUST00000026571.4 |
Irf7
|
interferon regulatory factor 7 |
chr5_-_134229581 | 1.68 |
ENSMUST00000111275.1
ENSMUST00000016094.6 ENSMUST00000144086.1 |
Ncf1
|
neutrophil cytosolic factor 1 |
chr7_-_143460989 | 1.65 |
ENSMUST00000167912.1
ENSMUST00000037287.6 |
Cdkn1c
|
cyclin-dependent kinase inhibitor 1C (P57) |
chr16_-_10785525 | 1.63 |
ENSMUST00000038099.4
|
Socs1
|
suppressor of cytokine signaling 1 |
chr13_+_33004528 | 1.62 |
ENSMUST00000006391.4
|
Serpinb9
|
serine (or cysteine) peptidase inhibitor, clade B, member 9 |
chr9_+_5298517 | 1.56 |
ENSMUST00000027015.5
|
Casp1
|
caspase 1 |
chr2_-_51972990 | 1.55 |
ENSMUST00000145481.1
ENSMUST00000112705.2 |
Nmi
|
N-myc (and STAT) interactor |
chr12_-_78980758 | 1.49 |
ENSMUST00000174072.1
|
Tmem229b
|
transmembrane protein 229B |
chr1_+_16688405 | 1.44 |
ENSMUST00000026881.4
|
Ly96
|
lymphocyte antigen 96 |
chr17_-_36042690 | 1.43 |
ENSMUST00000058801.8
ENSMUST00000080015.5 ENSMUST00000077960.6 |
H2-T22
|
histocompatibility 2, T region locus 22 |
chr9_+_107975529 | 1.41 |
ENSMUST00000035216.4
|
Uba7
|
ubiquitin-like modifier activating enzyme 7 |
chr5_+_114896936 | 1.40 |
ENSMUST00000031542.9
ENSMUST00000146072.1 ENSMUST00000150361.1 |
Oasl2
|
2'-5' oligoadenylate synthetase-like 2 |
chr12_-_26456423 | 1.39 |
ENSMUST00000020970.7
|
Rsad2
|
radical S-adenosyl methionine domain containing 2 |
chr10_-_75797728 | 1.37 |
ENSMUST00000139724.1
|
Gstt1
|
glutathione S-transferase, theta 1 |
chr6_-_125231772 | 1.32 |
ENSMUST00000043422.7
|
Tapbpl
|
TAP binding protein-like |
chr7_-_45136102 | 1.31 |
ENSMUST00000125500.1
|
Flt3l
|
FMS-like tyrosine kinase 3 ligand |
chr10_+_128270546 | 1.30 |
ENSMUST00000105238.3
ENSMUST00000085708.2 |
Stat2
|
signal transducer and activator of transcription 2 |
chr19_-_11050500 | 1.29 |
ENSMUST00000099676.4
|
AW112010
|
expressed sequence AW112010 |
chr7_+_97453204 | 1.29 |
ENSMUST00000050732.7
ENSMUST00000121987.1 |
Kctd14
|
potassium channel tetramerisation domain containing 14 |
chr1_-_155146755 | 1.29 |
ENSMUST00000027744.8
|
Mr1
|
major histocompatibility complex, class I-related |
chr11_+_58199556 | 1.28 |
ENSMUST00000035266.4
ENSMUST00000094169.4 ENSMUST00000168280.1 ENSMUST00000058704.8 |
Igtp
Irgm2
|
interferon gamma induced GTPase immunity-related GTPase family M member 2 |
chr7_-_104353328 | 1.27 |
ENSMUST00000130139.1
ENSMUST00000059037.8 |
Trim12c
|
tripartite motif-containing 12C |
chr11_+_32000452 | 1.27 |
ENSMUST00000020537.2
ENSMUST00000109409.1 |
Nsg2
|
neuron specific gene family member 2 |
chr5_+_117357274 | 1.26 |
ENSMUST00000031309.9
|
Wsb2
|
WD repeat and SOCS box-containing 2 |
chr19_+_6164433 | 1.25 |
ENSMUST00000045042.7
|
Batf2
|
basic leucine zipper transcription factor, ATF-like 2 |
chr6_+_39381175 | 1.24 |
ENSMUST00000031986.4
|
Rab19
|
RAB19, member RAS oncogene family |
chr4_-_145246855 | 1.22 |
ENSMUST00000030336.4
|
Tnfrsf1b
|
tumor necrosis factor receptor superfamily, member 1b |
chr1_-_156674290 | 1.21 |
ENSMUST00000079625.4
|
Tor3a
|
torsin family 3, member A |
chr17_+_36837123 | 1.21 |
ENSMUST00000179968.1
ENSMUST00000130367.1 ENSMUST00000130801.1 ENSMUST00000144182.1 ENSMUST00000123715.1 ENSMUST00000053434.8 |
Trim26
|
tripartite motif-containing 26 |
chr1_-_85598796 | 1.21 |
ENSMUST00000093508.6
|
Sp110
|
Sp110 nuclear body protein |
chr15_+_99392882 | 1.20 |
ENSMUST00000023749.8
|
Tmbim6
|
transmembrane BAX inhibitor motif containing 6 |
chr3_-_96263311 | 1.18 |
ENSMUST00000171473.1
|
Hist2h4
|
histone cluster 2, H4 |
chr2_+_104069819 | 1.17 |
ENSMUST00000111131.2
ENSMUST00000111132.1 ENSMUST00000129749.1 |
Cd59b
|
CD59b antigen |
chr19_+_34607927 | 1.16 |
ENSMUST00000076249.5
|
I830012O16Rik
|
RIKEN cDNA I830012O16 gene |
chr12_+_26469204 | 1.14 |
ENSMUST00000020969.3
|
Cmpk2
|
cytidine monophosphate (UMP-CMP) kinase 2, mitochondrial |
chr11_+_69964758 | 1.11 |
ENSMUST00000108597.1
ENSMUST00000060651.5 ENSMUST00000108596.1 |
Cldn7
|
claudin 7 |
chrX_-_134161928 | 1.10 |
ENSMUST00000033611.4
|
Xkrx
|
X Kell blood group precursor related X linked |
chr1_-_184732444 | 1.09 |
ENSMUST00000174257.1
|
Hlx
|
H2.0-like homeobox |
chr19_+_55741810 | 1.09 |
ENSMUST00000111657.3
ENSMUST00000061496.9 ENSMUST00000041717.7 ENSMUST00000111662.4 |
Tcf7l2
|
transcription factor 7 like 2, T cell specific, HMG box |
chr1_+_52119438 | 1.08 |
ENSMUST00000070968.7
|
Stat1
|
signal transducer and activator of transcription 1 |
chr2_-_167062981 | 1.07 |
ENSMUST00000048988.7
|
Znfx1
|
zinc finger, NFX1-type containing 1 |
chr17_-_34862473 | 1.07 |
ENSMUST00000025229.4
ENSMUST00000176203.2 ENSMUST00000128767.1 |
Cfb
|
complement factor B |
chr7_-_45136056 | 1.06 |
ENSMUST00000130628.1
|
Flt3l
|
FMS-like tyrosine kinase 3 ligand |
chr12_+_103434211 | 1.06 |
ENSMUST00000079294.5
ENSMUST00000076788.5 ENSMUST00000076702.5 ENSMUST00000066701.6 ENSMUST00000085065.5 ENSMUST00000140838.1 |
Ifi27
|
interferon, alpha-inducible protein 27 |
chr2_-_51934943 | 1.06 |
ENSMUST00000102767.1
ENSMUST00000102768.1 |
Rbm43
|
RNA binding motif protein 43 |
chr11_+_29718563 | 1.06 |
ENSMUST00000060992.5
|
Rtn4
|
reticulon 4 |
chr19_+_29410919 | 1.06 |
ENSMUST00000112576.2
|
Pdcd1lg2
|
programmed cell death 1 ligand 2 |
chr2_-_103283760 | 1.04 |
ENSMUST00000111174.1
|
Ehf
|
ets homologous factor |
chr11_+_49087022 | 1.04 |
ENSMUST00000046704.6
|
Ifi47
|
interferon gamma inducible protein 47 |
chr4_+_45972233 | 1.00 |
ENSMUST00000102929.1
|
Tdrd7
|
tudor domain containing 7 |
chr8_+_127064107 | 0.99 |
ENSMUST00000162536.1
ENSMUST00000026921.6 ENSMUST00000162665.1 ENSMUST00000160766.1 ENSMUST00000162602.1 ENSMUST00000162531.1 ENSMUST00000160581.1 ENSMUST00000161355.1 ENSMUST00000159537.1 |
Pard3
|
par-3 (partitioning defective 3) homolog (C. elegans) |
chr2_+_122147680 | 0.98 |
ENSMUST00000102476.4
|
B2m
|
beta-2 microglobulin |
chr9_-_111057235 | 0.97 |
ENSMUST00000111888.1
|
Ccrl2
|
chemokine (C-C motif) receptor-like 2 |
chr6_+_96113146 | 0.96 |
ENSMUST00000122120.1
|
Fam19a1
|
family with sequence similarity 19, member A1 |
chr9_+_38718263 | 0.96 |
ENSMUST00000001544.5
ENSMUST00000118144.1 |
Vwa5a
|
von Willebrand factor A domain containing 5A |
chr1_+_130826676 | 0.95 |
ENSMUST00000027675.7
|
Pigr
|
polymeric immunoglobulin receptor |
chr5_-_105239533 | 0.95 |
ENSMUST00000065588.6
|
Gbp10
|
guanylate-binding protein 10 |
chr11_+_70459940 | 0.94 |
ENSMUST00000147289.1
ENSMUST00000126105.1 |
Zmynd15
|
zinc finger, MYND-type containing 15 |
chrX_-_9469288 | 0.93 |
ENSMUST00000015484.3
|
Cybb
|
cytochrome b-245, beta polypeptide |
chr2_+_165055625 | 0.92 |
ENSMUST00000017799.5
ENSMUST00000073707.2 |
Cd40
|
CD40 antigen |
chr11_-_48992226 | 0.91 |
ENSMUST00000059930.2
ENSMUST00000068063.3 |
Gm12185
Tgtp1
|
predicted gene 12185 T cell specific GTPase 1 |
chr12_+_37241729 | 0.90 |
ENSMUST00000160768.1
|
Agmo
|
alkylglycerol monooxygenase |
chr14_+_77904239 | 0.89 |
ENSMUST00000022591.8
|
Epsti1
|
epithelial stromal interaction 1 (breast) |
chr19_+_5406815 | 0.89 |
ENSMUST00000174412.1
ENSMUST00000153017.2 |
4930481A15Rik
|
RIKEN cDNA 4930481A15 gene |
chr11_-_78984946 | 0.89 |
ENSMUST00000108268.3
|
Lgals9
|
lectin, galactose binding, soluble 9 |
chr8_-_111338152 | 0.88 |
ENSMUST00000056157.7
ENSMUST00000120432.1 |
Mlkl
|
mixed lineage kinase domain-like |
chr2_-_51934644 | 0.88 |
ENSMUST00000165313.1
|
Rbm43
|
RNA binding motif protein 43 |
chr11_-_70459957 | 0.87 |
ENSMUST00000019064.2
|
Cxcl16
|
chemokine (C-X-C motif) ligand 16 |
chr11_+_101582236 | 0.87 |
ENSMUST00000039581.7
ENSMUST00000100403.2 ENSMUST00000107194.1 ENSMUST00000128614.1 |
Tmem106a
|
transmembrane protein 106A |
chr13_+_37345338 | 0.85 |
ENSMUST00000021860.5
|
Ly86
|
lymphocyte antigen 86 |
chr4_+_111719975 | 0.84 |
ENSMUST00000038868.7
ENSMUST00000070513.6 ENSMUST00000153746.1 |
Spata6
|
spermatogenesis associated 6 |
chr1_-_184732616 | 0.84 |
ENSMUST00000048572.6
|
Hlx
|
H2.0-like homeobox |
chr1_-_174031712 | 0.84 |
ENSMUST00000059226.6
|
Ifi205
|
interferon activated gene 205 |
chr4_+_135728116 | 0.84 |
ENSMUST00000102546.3
|
Il22ra1
|
interleukin 22 receptor, alpha 1 |
chr6_-_54972603 | 0.83 |
ENSMUST00000060655.8
|
Nod1
|
nucleotide-binding oligomerization domain containing 1 |
chr19_+_34583528 | 0.83 |
ENSMUST00000102825.3
|
Ifit3
|
interferon-induced protein with tetratricopeptide repeats 3 |
chr9_-_45204083 | 0.83 |
ENSMUST00000034599.8
|
Tmprss4
|
transmembrane protease, serine 4 |
chr9_-_106476590 | 0.83 |
ENSMUST00000112479.2
|
Parp3
|
poly (ADP-ribose) polymerase family, member 3 |
chr5_+_117319292 | 0.82 |
ENSMUST00000086464.4
|
Vsig10
|
V-set and immunoglobulin domain containing 10 |
chr5_+_35056813 | 0.82 |
ENSMUST00000101298.2
ENSMUST00000114270.1 ENSMUST00000133381.1 |
Dok7
|
docking protein 7 |
chr15_-_98296083 | 0.82 |
ENSMUST00000169721.1
ENSMUST00000023722.5 |
Zfp641
|
zinc finger protein 641 |
chr8_-_122551316 | 0.82 |
ENSMUST00000067252.7
|
Piezo1
|
piezo-type mechanosensitive ion channel component 1 |
chr16_+_97536079 | 0.80 |
ENSMUST00000024112.7
|
Mx2
|
myxovirus (influenza virus) resistance 2 |
chr6_-_39118211 | 0.80 |
ENSMUST00000038398.6
|
Parp12
|
poly (ADP-ribose) polymerase family, member 12 |
chr3_-_32616479 | 0.79 |
ENSMUST00000108234.1
ENSMUST00000155737.1 |
Gnb4
|
guanine nucleotide binding protein (G protein), beta 4 |
chr18_+_37447641 | 0.79 |
ENSMUST00000052387.3
|
Pcdhb14
|
protocadherin beta 14 |
chr9_+_5345414 | 0.78 |
ENSMUST00000027009.4
|
Casp12
|
caspase 12 |
chr2_-_24049389 | 0.78 |
ENSMUST00000051416.5
|
Hnmt
|
histamine N-methyltransferase |
chr6_+_145121727 | 0.77 |
ENSMUST00000032396.6
|
Lrmp
|
lymphoid-restricted membrane protein |
chr5_-_120777628 | 0.77 |
ENSMUST00000044833.8
|
Oas3
|
2'-5' oligoadenylate synthetase 3 |
chr11_-_49064202 | 0.77 |
ENSMUST00000046745.6
|
Tgtp2
|
T cell specific GTPase 2 |
chr11_+_61065798 | 0.77 |
ENSMUST00000041944.2
ENSMUST00000108717.2 |
Kcnj12
|
potassium inwardly-rectifying channel, subfamily J, member 12 |
chr11_-_78984831 | 0.76 |
ENSMUST00000073001.4
ENSMUST00000108269.3 |
Lgals9
|
lectin, galactose binding, soluble 9 |
chr11_-_3931789 | 0.75 |
ENSMUST00000109992.1
ENSMUST00000109988.1 |
Tcn2
|
transcobalamin 2 |
chr5_+_147269959 | 0.75 |
ENSMUST00000085591.5
|
Pdx1
|
pancreatic and duodenal homeobox 1 |
chr17_-_34187219 | 0.74 |
ENSMUST00000173831.1
|
Psmb9
|
proteasome (prosome, macropain) subunit, beta type 9 (large multifunctional peptidase 2) |
chr5_+_117319258 | 0.74 |
ENSMUST00000111967.1
|
Vsig10
|
V-set and immunoglobulin domain containing 10 |
chr16_+_35938470 | 0.73 |
ENSMUST00000114878.1
|
Parp9
|
poly (ADP-ribose) polymerase family, member 9 |
chr5_-_120907510 | 0.73 |
ENSMUST00000080322.7
|
Oas1a
|
2'-5' oligoadenylate synthetase 1A |
chr2_-_62646146 | 0.72 |
ENSMUST00000112459.3
ENSMUST00000028259.5 |
Ifih1
|
interferon induced with helicase C domain 1 |
chr8_-_82403203 | 0.72 |
ENSMUST00000034148.6
|
Il15
|
interleukin 15 |
chr5_+_67260794 | 0.71 |
ENSMUST00000161369.1
|
Tmem33
|
transmembrane protein 33 |
chr4_-_46536134 | 0.71 |
ENSMUST00000046897.6
|
Trim14
|
tripartite motif-containing 14 |
chr1_-_173599074 | 0.71 |
ENSMUST00000150649.1
ENSMUST00000180215.1 ENSMUST00000097462.2 |
Pydc4
|
pyrin domain containing 4 |
chr10_+_116177217 | 0.70 |
ENSMUST00000148731.1
|
Ptprr
|
protein tyrosine phosphatase, receptor type, R |
chr13_+_56609516 | 0.70 |
ENSMUST00000045173.8
|
Tgfbi
|
transforming growth factor, beta induced |
chr11_+_43474276 | 0.70 |
ENSMUST00000173002.1
ENSMUST00000057679.3 |
C1qtnf2
|
C1q and tumor necrosis factor related protein 2 |
chr8_+_105427634 | 0.70 |
ENSMUST00000067305.6
|
Lrrc36
|
leucine rich repeat containing 36 |
chr13_+_42866247 | 0.69 |
ENSMUST00000131942.1
|
Phactr1
|
phosphatase and actin regulator 1 |
chr9_-_117252450 | 0.69 |
ENSMUST00000111773.3
ENSMUST00000068962.7 ENSMUST00000044901.7 |
Rbms3
|
RNA binding motif, single stranded interacting protein |
chr2_+_24385313 | 0.69 |
ENSMUST00000056641.8
|
Psd4
|
pleckstrin and Sec7 domain containing 4 |
chr1_+_58711488 | 0.69 |
ENSMUST00000097722.2
ENSMUST00000114313.1 |
Cflar
|
CASP8 and FADD-like apoptosis regulator |
chr3_-_59130610 | 0.69 |
ENSMUST00000065220.6
ENSMUST00000091112.4 |
P2ry14
|
purinergic receptor P2Y, G-protein coupled, 14 |
chr5_-_120749848 | 0.68 |
ENSMUST00000053909.6
ENSMUST00000081491.6 |
Oas2
|
2'-5' oligoadenylate synthetase 2 |
chr2_-_51973219 | 0.68 |
ENSMUST00000028314.2
|
Nmi
|
N-myc (and STAT) interactor |
chr6_+_41392356 | 0.67 |
ENSMUST00000049079.7
|
Gm5771
|
predicted gene 5771 |
chr17_+_29660710 | 0.67 |
ENSMUST00000130423.1
|
Cmtr1
|
cap methyltransferase 1 |
chr14_+_103513328 | 0.67 |
ENSMUST00000095576.3
|
Scel
|
sciellin |
chr11_+_58215028 | 0.67 |
ENSMUST00000108836.1
|
Irgm2
|
immunity-related GTPase family M member 2 |
chr18_-_3299452 | 0.66 |
ENSMUST00000126578.1
|
Crem
|
cAMP responsive element modulator |
chr17_-_36020525 | 0.66 |
ENSMUST00000174063.1
ENSMUST00000113760.3 |
H2-T24
|
histocompatibility 2, T region locus 24 |
chr1_-_173490933 | 0.66 |
ENSMUST00000160565.2
|
Gm4955
|
predicted gene 4955 |
chr8_-_35826435 | 0.65 |
ENSMUST00000060128.5
|
Cldn23
|
claudin 23 |
chr3_+_95526777 | 0.65 |
ENSMUST00000015667.2
ENSMUST00000116304.2 |
Ctss
|
cathepsin S |
chr7_+_43797567 | 0.65 |
ENSMUST00000085461.2
|
Klk8
|
kallikrein related-peptidase 8 |
chr5_-_117319242 | 0.65 |
ENSMUST00000100834.1
|
Gm10399
|
predicted gene 10399 |
chr5_+_114923234 | 0.64 |
ENSMUST00000031540.4
ENSMUST00000112143.3 |
Oasl1
|
2'-5' oligoadenylate synthetase-like 1 |
chr1_-_192092540 | 0.64 |
ENSMUST00000085573.6
|
Traf5
|
TNF receptor-associated factor 5 |
chr3_+_27317028 | 0.64 |
ENSMUST00000046383.5
ENSMUST00000174840.1 |
Tnfsf10
|
tumor necrosis factor (ligand) superfamily, member 10 |
chr10_-_88356990 | 0.63 |
ENSMUST00000020249.1
|
Dram1
|
DNA-damage regulated autophagy modulator 1 |
chr18_-_3299537 | 0.63 |
ENSMUST00000129435.1
ENSMUST00000122958.1 |
Crem
|
cAMP responsive element modulator |
chr8_+_35375719 | 0.63 |
ENSMUST00000070481.6
|
Ppp1r3b
|
protein phosphatase 1, regulatory (inhibitor) subunit 3B |
chr16_-_24393588 | 0.63 |
ENSMUST00000181640.1
|
1110054M08Rik
|
RIKEN cDNA 1110054M08 gene |
chr10_-_75797528 | 0.62 |
ENSMUST00000120177.1
|
Gstt1
|
glutathione S-transferase, theta 1 |
chr10_+_116177351 | 0.62 |
ENSMUST00000155606.1
ENSMUST00000128399.1 |
Ptprr
|
protein tyrosine phosphatase, receptor type, R |
chr5_-_137116177 | 0.62 |
ENSMUST00000054384.5
ENSMUST00000152207.1 |
Trim56
|
tripartite motif-containing 56 |
chr5_-_52471534 | 0.62 |
ENSMUST00000059428.5
|
Ccdc149
|
coiled-coil domain containing 149 |
chr10_+_78069351 | 0.62 |
ENSMUST00000105393.1
|
Icosl
|
icos ligand |
chr17_+_37270214 | 0.62 |
ENSMUST00000038580.6
|
H2-M3
|
histocompatibility 2, M region locus 3 |
chr11_-_48871344 | 0.62 |
ENSMUST00000049519.3
|
Irgm1
|
immunity-related GTPase family M member 1 |
chr5_-_105139539 | 0.62 |
ENSMUST00000100961.4
ENSMUST00000031235.6 ENSMUST00000100962.3 |
Gbp9
Gbp8
Gbp4
|
guanylate-binding protein 9 guanylate-binding protein 8 guanylate binding protein 4 |
chr1_-_156036473 | 0.61 |
ENSMUST00000097527.3
ENSMUST00000027738.7 |
Tor1aip1
|
torsin A interacting protein 1 |
chr4_+_111720187 | 0.61 |
ENSMUST00000084354.3
|
Spata6
|
spermatogenesis associated 6 |
chr19_-_45591820 | 0.61 |
ENSMUST00000160003.1
ENSMUST00000162879.1 |
Fbxw4
|
F-box and WD-40 domain protein 4 |
chr4_+_54947976 | 0.61 |
ENSMUST00000098070.3
|
Zfp462
|
zinc finger protein 462 |
chr11_-_102296618 | 0.61 |
ENSMUST00000107132.2
ENSMUST00000073234.2 |
Atxn7l3
|
ataxin 7-like 3 |
chr9_+_118040475 | 0.61 |
ENSMUST00000044454.5
|
Azi2
|
5-azacytidine induced gene 2 |
chr7_+_58658181 | 0.60 |
ENSMUST00000168747.1
|
Atp10a
|
ATPase, class V, type 10A |
chr2_-_77170592 | 0.60 |
ENSMUST00000164114.2
ENSMUST00000049544.7 |
Ccdc141
|
coiled-coil domain containing 141 |
chr5_-_65492984 | 0.60 |
ENSMUST00000139122.1
|
Smim14
|
small integral membrane protein 14 |
chr5_-_105293699 | 0.60 |
ENSMUST00000050011.8
|
Gbp6
|
guanylate binding protein 6 |
chr12_+_51377560 | 0.59 |
ENSMUST00000021335.5
|
Scfd1
|
Sec1 family domain containing 1 |
chr5_-_92348871 | 0.59 |
ENSMUST00000038816.6
ENSMUST00000118006.1 |
Cxcl10
|
chemokine (C-X-C motif) ligand 10 |
chr11_-_100704217 | 0.59 |
ENSMUST00000017974.6
|
Dhx58
|
DEXH (Asp-Glu-X-His) box polypeptide 58 |
chr7_+_80860909 | 0.59 |
ENSMUST00000132163.1
ENSMUST00000147125.1 |
Zscan2
|
zinc finger and SCAN domain containing 2 |
chr3_-_59262825 | 0.59 |
ENSMUST00000050360.7
|
P2ry12
|
purinergic receptor P2Y, G-protein coupled 12 |
chr6_+_7555053 | 0.59 |
ENSMUST00000090679.2
ENSMUST00000184986.1 |
Tac1
|
tachykinin 1 |
chr3_+_127791374 | 0.58 |
ENSMUST00000171621.1
|
Tifa
|
TRAF-interacting protein with forkhead-associated domain |
chr6_-_129237948 | 0.58 |
ENSMUST00000181238.1
ENSMUST00000180379.1 |
2310001H17Rik
|
RIKEN cDNA 2310001H17 gene |
chr9_-_14381242 | 0.58 |
ENSMUST00000167549.1
|
Endod1
|
endonuclease domain containing 1 |
chr1_+_130826762 | 0.58 |
ENSMUST00000133792.1
|
Pigr
|
polymeric immunoglobulin receptor |
chr14_+_41105359 | 0.57 |
ENSMUST00000047286.6
|
Mat1a
|
methionine adenosyltransferase I, alpha |
chr7_+_139248477 | 0.57 |
ENSMUST00000093993.3
ENSMUST00000172136.1 |
Pwwp2b
|
PWWP domain containing 2B |
chr3_+_142530329 | 0.57 |
ENSMUST00000171263.1
ENSMUST00000045097.9 |
Gbp7
|
guanylate binding protein 7 |
chr3_+_8509477 | 0.57 |
ENSMUST00000029002.7
|
Stmn2
|
stathmin-like 2 |
chr1_+_173630847 | 0.57 |
ENSMUST00000056071.7
|
Pyhin1
|
pyrin and HIN domain family, member 1 |
chr13_-_23710714 | 0.56 |
ENSMUST00000091707.6
ENSMUST00000006787.7 ENSMUST00000091706.6 |
Hfe
|
hemochromatosis |
chr5_-_120812506 | 0.56 |
ENSMUST00000117193.1
ENSMUST00000130045.1 |
Oas1c
|
2'-5' oligoadenylate synthetase 1C |
chr3_-_137981523 | 0.56 |
ENSMUST00000136613.1
ENSMUST00000029806.6 |
Dapp1
|
dual adaptor for phosphotyrosine and 3-phosphoinositides 1 |
chr11_-_109298066 | 0.56 |
ENSMUST00000106706.1
|
Rgs9
|
regulator of G-protein signaling 9 |
chr9_-_54950954 | 0.55 |
ENSMUST00000054018.5
|
AY074887
|
cDNA sequence AY074887 |
chr2_-_173276144 | 0.55 |
ENSMUST00000139306.1
|
Pmepa1
|
prostate transmembrane protein, androgen induced 1 |
chr9_+_118040509 | 0.55 |
ENSMUST00000133580.1
|
Azi2
|
5-azacytidine induced gene 2 |
chr7_-_45136391 | 0.55 |
ENSMUST00000146760.1
|
Flt3l
|
FMS-like tyrosine kinase 3 ligand |
chr16_-_97462903 | 0.55 |
ENSMUST00000142883.1
ENSMUST00000113768.1 ENSMUST00000023655.6 |
Mx1
|
myxovirus (influenza virus) resistance 1 |
chr9_-_103761820 | 0.55 |
ENSMUST00000049452.8
|
Tmem108
|
transmembrane protein 108 |
chr7_-_46715676 | 0.55 |
ENSMUST00000006956.7
|
Saa3
|
serum amyloid A 3 |
chr2_+_58754910 | 0.54 |
ENSMUST00000059102.6
|
Upp2
|
uridine phosphorylase 2 |
chr4_+_40948401 | 0.54 |
ENSMUST00000030128.5
|
Chmp5
|
charged multivesicular body protein 5 |
chr11_+_114851142 | 0.54 |
ENSMUST00000133245.1
ENSMUST00000122967.2 |
Gprc5c
|
G protein-coupled receptor, family C, group 5, member C |
chr12_+_52699297 | 0.53 |
ENSMUST00000095737.3
|
Akap6
|
A kinase (PRKA) anchor protein 6 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 4.3 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
1.3 | 1.3 | GO:0002589 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) |
0.9 | 4.5 | GO:0009597 | detection of virus(GO:0009597) |
0.8 | 1.6 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.7 | 2.2 | GO:1902524 | positive regulation of protein K48-linked ubiquitination(GO:1902524) |
0.7 | 2.0 | GO:0042196 | dichloromethane metabolic process(GO:0018900) chlorinated hydrocarbon metabolic process(GO:0042196) halogenated hydrocarbon metabolic process(GO:0042197) |
0.6 | 1.7 | GO:0001878 | response to yeast(GO:0001878) |
0.5 | 1.5 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.5 | 1.9 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
0.5 | 1.4 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
0.5 | 2.3 | GO:1904721 | regulation of mRNA cleavage(GO:0031437) negative regulation of mRNA cleavage(GO:0031438) regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904720) negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904721) |
0.4 | 5.9 | GO:0002483 | antigen processing and presentation of endogenous peptide antigen(GO:0002483) |
0.4 | 1.5 | GO:0002415 | immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
0.4 | 1.1 | GO:0009197 | dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate metabolic process(GO:0009138) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dUDP metabolic process(GO:0046077) |
0.3 | 1.4 | GO:0044565 | dendritic cell proliferation(GO:0044565) |
0.3 | 1.0 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
0.3 | 1.7 | GO:0034124 | regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) |
0.3 | 0.3 | GO:1990009 | retinal cell apoptotic process(GO:1990009) |
0.3 | 1.6 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) |
0.3 | 1.9 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
0.3 | 1.3 | GO:1901740 | negative regulation of myoblast fusion(GO:1901740) |
0.3 | 1.2 | GO:1903896 | positive regulation of IRE1-mediated unfolded protein response(GO:1903896) |
0.3 | 1.2 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.3 | 0.9 | GO:0045404 | positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.3 | 2.0 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
0.3 | 1.1 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.3 | 9.8 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.3 | 1.1 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.3 | 1.6 | GO:0010533 | regulation of activation of Janus kinase activity(GO:0010533) |
0.3 | 3.8 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.3 | 0.8 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.3 | 2.3 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.2 | 1.2 | GO:0034239 | regulation of macrophage fusion(GO:0034239) |
0.2 | 0.7 | GO:1904100 | interleukin-15-mediated signaling pathway(GO:0035723) extrathymic T cell selection(GO:0045062) cellular response to interleukin-15(GO:0071350) regulation of protein O-linked glycosylation(GO:1904098) positive regulation of protein O-linked glycosylation(GO:1904100) |
0.2 | 2.8 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.2 | 1.2 | GO:0045918 | negative regulation of cytolysis(GO:0045918) |
0.2 | 1.3 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.2 | 1.3 | GO:0003383 | apical constriction(GO:0003383) |
0.2 | 0.6 | GO:1990166 | protein localization to site of double-strand break(GO:1990166) |
0.2 | 0.6 | GO:0035934 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.2 | 1.5 | GO:1902746 | regulation of lens fiber cell differentiation(GO:1902746) |
0.2 | 0.6 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.2 | 0.5 | GO:0061763 | multivesicular body-lysosome fusion(GO:0061763) |
0.2 | 0.7 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.2 | 0.5 | GO:0061357 | positive regulation of Wnt protein secretion(GO:0061357) |
0.2 | 1.7 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.2 | 0.5 | GO:0046351 | disaccharide biosynthetic process(GO:0046351) |
0.2 | 1.2 | GO:1901098 | positive regulation of autophagosome maturation(GO:1901098) |
0.2 | 0.8 | GO:0009730 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.2 | 0.7 | GO:0034769 | basement membrane disassembly(GO:0034769) |
0.2 | 0.5 | GO:0019442 | tryptophan catabolic process to acetyl-CoA(GO:0019442) |
0.2 | 1.3 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.2 | 0.8 | GO:0052805 | imidazole-containing compound catabolic process(GO:0052805) |
0.2 | 0.5 | GO:0002014 | vasoconstriction of artery involved in ischemic response to lowering of systemic arterial blood pressure(GO:0002014) |
0.1 | 0.4 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
0.1 | 0.6 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.1 | 2.7 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
0.1 | 0.4 | GO:0007161 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) calcium-independent cell-matrix adhesion(GO:0007161) |
0.1 | 0.7 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) |
0.1 | 0.7 | GO:0098886 | modification of dendritic spine(GO:0098886) |
0.1 | 0.8 | GO:0015889 | cobalamin transport(GO:0015889) |
0.1 | 0.4 | GO:0097309 | cap1 mRNA methylation(GO:0097309) |
0.1 | 0.4 | GO:0002302 | CD8-positive, alpha-beta T cell differentiation involved in immune response(GO:0002302) |
0.1 | 0.4 | GO:1900247 | cytoplasmic translational elongation(GO:0002182) regulation of cytoplasmic translational elongation(GO:1900247) negative regulation of cytoplasmic translational elongation(GO:1900248) |
0.1 | 0.3 | GO:1902523 | positive regulation of protein K63-linked ubiquitination(GO:1902523) |
0.1 | 0.4 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.1 | 0.6 | GO:0002606 | positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
0.1 | 1.1 | GO:0048625 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition(GO:0044334) embryonic hindgut morphogenesis(GO:0048619) myoblast fate commitment(GO:0048625) |
0.1 | 0.7 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.1 | 0.3 | GO:0019085 | early viral transcription(GO:0019085) |
0.1 | 1.3 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.1 | 0.6 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.1 | 0.3 | GO:0071332 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) cellular response to fructose stimulus(GO:0071332) |
0.1 | 0.7 | GO:0036476 | neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
0.1 | 0.2 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.1 | 0.2 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.1 | 0.3 | GO:2000563 | endocardial cushion fusion(GO:0003274) positive regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000563) |
0.1 | 1.4 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.1 | 0.5 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
0.1 | 0.5 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.1 | 0.3 | GO:0002730 | regulation of dendritic cell cytokine production(GO:0002730) |
0.1 | 0.2 | GO:0031296 | B cell costimulation(GO:0031296) |
0.1 | 0.2 | GO:0072734 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
0.1 | 0.4 | GO:0001905 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
0.1 | 1.2 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.1 | 0.3 | GO:0071211 | protein targeting to vacuole involved in autophagy(GO:0071211) |
0.1 | 0.7 | GO:0018377 | protein myristoylation(GO:0018377) |
0.1 | 0.3 | GO:1905204 | negative regulation of connective tissue replacement(GO:1905204) |
0.1 | 0.5 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.1 | 0.7 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.1 | 0.9 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.1 | 0.5 | GO:0045625 | regulation of T-helper 1 cell differentiation(GO:0045625) |
0.1 | 0.3 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) chemokine (C-X-C motif) ligand 1 production(GO:0072566) regulation of chemokine (C-X-C motif) ligand 1 production(GO:2000338) |
0.1 | 0.6 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
0.1 | 0.5 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
0.1 | 0.5 | GO:0040032 | post-embryonic body morphogenesis(GO:0040032) |
0.1 | 0.3 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.1 | 0.3 | GO:0048239 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
0.1 | 0.7 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.1 | 0.3 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
0.1 | 0.5 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.1 | 0.5 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.1 | 0.1 | GO:0018307 | enzyme active site formation(GO:0018307) |
0.1 | 1.7 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.1 | 0.6 | GO:1990416 | cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
0.1 | 1.1 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
0.1 | 0.2 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.1 | 0.6 | GO:0010700 | negative regulation of norepinephrine secretion(GO:0010700) |
0.1 | 0.3 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.1 | 0.4 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
0.1 | 0.3 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.1 | 0.2 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
0.1 | 0.7 | GO:0035878 | nail development(GO:0035878) |
0.1 | 0.2 | GO:1904569 | regulation of selenocysteine incorporation(GO:1904569) |
0.1 | 0.4 | GO:0048133 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.1 | 0.5 | GO:0032621 | interleukin-18 production(GO:0032621) |
0.1 | 0.7 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.1 | 0.2 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.1 | 1.1 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.1 | 0.3 | GO:0090290 | positive regulation of osteoclast proliferation(GO:0090290) |
0.1 | 0.7 | GO:0046321 | positive regulation of fatty acid oxidation(GO:0046321) |
0.1 | 0.6 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.1 | 0.3 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.1 | 0.3 | GO:0071449 | cellular response to lipid hydroperoxide(GO:0071449) |
0.1 | 0.3 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
0.1 | 0.3 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.1 | 0.2 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.1 | 0.9 | GO:0010818 | T cell chemotaxis(GO:0010818) |
0.1 | 0.2 | GO:0002223 | stimulatory C-type lectin receptor signaling pathway(GO:0002223) |
0.1 | 0.2 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.1 | 10.6 | GO:0051607 | defense response to virus(GO:0051607) |
0.1 | 1.2 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.1 | 0.2 | GO:0003245 | cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) |
0.1 | 0.2 | GO:0051342 | regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.1 | 0.2 | GO:0070459 | prolactin secretion(GO:0070459) |
0.1 | 0.4 | GO:0042095 | interferon-gamma biosynthetic process(GO:0042095) |
0.1 | 1.1 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.1 | 0.5 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.1 | 0.2 | GO:0090126 | protein complex assembly involved in synapse maturation(GO:0090126) |
0.1 | 2.4 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.1 | 1.3 | GO:0032620 | interleukin-17 production(GO:0032620) |
0.1 | 0.2 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) regulation of planar cell polarity pathway involved in axis elongation(GO:2000040) negative regulation of planar cell polarity pathway involved in axis elongation(GO:2000041) |
0.1 | 0.1 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.1 | 0.6 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.1 | 0.2 | GO:0014809 | regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
0.1 | 0.2 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.1 | 0.2 | GO:1904457 | positive regulation of neuronal action potential(GO:1904457) |
0.1 | 0.2 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.0 | 0.2 | GO:0035608 | protein deglutamylation(GO:0035608) protein side chain deglutamylation(GO:0035610) |
0.0 | 0.1 | GO:0036022 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
0.0 | 0.1 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.0 | 0.2 | GO:1902037 | negative regulation of hematopoietic stem cell differentiation(GO:1902037) |
0.0 | 0.2 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.0 | 0.3 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.0 | 0.1 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.0 | 0.5 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.0 | 0.3 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
0.0 | 0.1 | GO:0002727 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) positive regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060369) |
0.0 | 0.5 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.0 | 0.1 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
0.0 | 0.4 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.0 | 2.7 | GO:0006687 | glycosphingolipid metabolic process(GO:0006687) |
0.0 | 6.7 | GO:0016052 | carbohydrate catabolic process(GO:0016052) |
0.0 | 0.3 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.0 | 0.3 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.0 | 0.4 | GO:0060923 | cardiac muscle cell fate commitment(GO:0060923) |
0.0 | 0.3 | GO:1904220 | regulation of serine C-palmitoyltransferase activity(GO:1904220) |
0.0 | 0.2 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.0 | 0.3 | GO:2000252 | negative regulation of feeding behavior(GO:2000252) |
0.0 | 0.2 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.0 | 0.3 | GO:0015808 | L-alanine transport(GO:0015808) |
0.0 | 0.7 | GO:0032291 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) long-chain fatty acid biosynthetic process(GO:0042759) |
0.0 | 0.8 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.0 | 0.6 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.0 | 0.2 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
0.0 | 0.2 | GO:0060022 | hard palate development(GO:0060022) |
0.0 | 0.4 | GO:2000406 | positive regulation of T cell migration(GO:2000406) |
0.0 | 0.4 | GO:0098543 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
0.0 | 0.4 | GO:0030432 | peristalsis(GO:0030432) |
0.0 | 0.1 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.0 | 0.3 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.0 | 0.6 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.0 | 0.2 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.0 | 0.4 | GO:0006968 | cellular defense response(GO:0006968) |
0.0 | 0.2 | GO:0039019 | pronephric nephron development(GO:0039019) |
0.0 | 0.1 | GO:1904879 | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
0.0 | 0.2 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.0 | 0.2 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.0 | 0.1 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.0 | 0.3 | GO:0006491 | N-glycan processing(GO:0006491) |
0.0 | 0.5 | GO:0030238 | male sex determination(GO:0030238) |
0.0 | 0.1 | GO:0097343 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.0 | 0.2 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
0.0 | 0.2 | GO:1902856 | negative regulation of nonmotile primary cilium assembly(GO:1902856) |
0.0 | 0.5 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) |
0.0 | 0.1 | GO:0061428 | peptidyl-aspartic acid hydroxylation(GO:0042264) negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
0.0 | 0.1 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.0 | 0.2 | GO:0072086 | proximal/distal pattern formation involved in nephron development(GO:0072047) specification of nephron tubule identity(GO:0072081) specification of loop of Henle identity(GO:0072086) |
0.0 | 0.1 | GO:1904565 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
0.0 | 0.7 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.0 | 0.1 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.0 | 0.2 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.0 | 0.3 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.0 | 0.3 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.0 | 0.1 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.0 | 0.9 | GO:0010107 | potassium ion import(GO:0010107) |
0.0 | 0.3 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.0 | 0.1 | GO:0006011 | UDP-glucose metabolic process(GO:0006011) |
0.0 | 0.2 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.0 | 0.3 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.0 | 0.4 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
0.0 | 0.4 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.0 | 0.3 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.0 | 0.3 | GO:0030853 | negative regulation of granulocyte differentiation(GO:0030853) |
0.0 | 0.6 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.0 | 0.5 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.0 | 0.9 | GO:0043392 | negative regulation of DNA binding(GO:0043392) |
0.0 | 0.2 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.0 | 0.1 | GO:0042695 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
0.0 | 0.2 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.0 | 0.1 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.0 | 0.1 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.0 | 0.4 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.0 | 0.3 | GO:0070266 | necroptotic process(GO:0070266) |
0.0 | 0.4 | GO:1903541 | regulation of exosomal secretion(GO:1903541) positive regulation of exosomal secretion(GO:1903543) |
0.0 | 0.4 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.0 | 0.3 | GO:0015812 | gamma-aminobutyric acid secretion(GO:0014051) gamma-aminobutyric acid transport(GO:0015812) |
0.0 | 0.1 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.0 | 0.6 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.0 | 0.1 | GO:0032379 | positive regulation of intracellular lipid transport(GO:0032379) positive regulation of intracellular sterol transport(GO:0032382) positive regulation of intracellular cholesterol transport(GO:0032385) lipid hydroperoxide transport(GO:1901373) |
0.0 | 0.2 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.0 | 0.4 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.0 | 0.1 | GO:1900003 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.0 | 0.0 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
0.0 | 0.1 | GO:0018101 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
0.0 | 0.3 | GO:0002347 | response to tumor cell(GO:0002347) |
0.0 | 0.5 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.0 | 0.1 | GO:0061193 | taste bud development(GO:0061193) |
0.0 | 0.1 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.0 | 0.1 | GO:0002232 | leukocyte chemotaxis involved in inflammatory response(GO:0002232) regulation of NAD(P)H oxidase activity(GO:0033860) phagosome acidification(GO:0090383) negative regulation of neutrophil migration(GO:1902623) |
0.0 | 0.2 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.0 | 0.7 | GO:0061098 | positive regulation of protein tyrosine kinase activity(GO:0061098) |
0.0 | 0.5 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.0 | 0.1 | GO:0035989 | tendon development(GO:0035989) |
0.0 | 0.2 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.0 | 0.2 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.0 | 0.4 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.0 | 0.1 | GO:1905051 | regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
0.0 | 0.2 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.0 | 0.1 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.0 | 0.2 | GO:0051231 | spindle elongation(GO:0051231) |
0.0 | 0.3 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.0 | 0.1 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.0 | 0.1 | GO:0051612 | negative regulation of neurotransmitter uptake(GO:0051581) negative regulation of serotonin uptake(GO:0051612) |
0.0 | 0.1 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.0 | 0.3 | GO:0006465 | signal peptide processing(GO:0006465) |
0.0 | 0.1 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.0 | 0.0 | GO:1904732 | regulation of electron carrier activity(GO:1904732) regulation of cytochrome-c oxidase activity(GO:1904959) |
0.0 | 0.2 | GO:0051601 | exocyst localization(GO:0051601) |
0.0 | 0.5 | GO:0051642 | centrosome localization(GO:0051642) |
0.0 | 0.1 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.0 | 0.2 | GO:0098719 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.0 | 0.1 | GO:0007343 | egg activation(GO:0007343) |
0.0 | 0.2 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.0 | 0.2 | GO:0035067 | negative regulation of histone acetylation(GO:0035067) |
0.0 | 0.1 | GO:2001166 | regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
0.0 | 0.7 | GO:0000271 | polysaccharide biosynthetic process(GO:0000271) |
0.0 | 0.1 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.0 | 0.7 | GO:0001919 | regulation of receptor recycling(GO:0001919) |
0.0 | 0.1 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
0.0 | 0.1 | GO:0070495 | regulation of thrombin receptor signaling pathway(GO:0070494) negative regulation of thrombin receptor signaling pathway(GO:0070495) |
0.0 | 0.1 | GO:0006983 | ER overload response(GO:0006983) |
0.0 | 0.1 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.0 | 0.1 | GO:0009816 | defense response, incompatible interaction(GO:0009814) defense response to bacterium, incompatible interaction(GO:0009816) regulation of defense response to bacterium, incompatible interaction(GO:1902477) |
0.0 | 0.2 | GO:0046337 | phosphatidylethanolamine metabolic process(GO:0046337) |
0.0 | 1.9 | GO:0042098 | T cell proliferation(GO:0042098) |
0.0 | 0.3 | GO:0019731 | antibacterial humoral response(GO:0019731) |
0.0 | 0.1 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
0.0 | 0.1 | GO:0045836 | positive regulation of meiotic nuclear division(GO:0045836) |
0.0 | 0.1 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.0 | 0.2 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.0 | 0.0 | GO:0019478 | aspartate catabolic process(GO:0006533) D-amino acid catabolic process(GO:0019478) |
0.0 | 0.1 | GO:0046851 | negative regulation of bone resorption(GO:0045779) negative regulation of bone remodeling(GO:0046851) |
0.0 | 0.1 | GO:2000576 | regulation of microtubule motor activity(GO:2000574) positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
0.0 | 0.3 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.0 | 0.2 | GO:0070831 | basement membrane assembly(GO:0070831) |
0.0 | 0.2 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.0 | 0.4 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.0 | 0.0 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.0 | 0.6 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.0 | 0.1 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
0.0 | 0.2 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.0 | 0.0 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 3.3 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.6 | 8.5 | GO:0020003 | symbiont-containing vacuole(GO:0020003) |
0.4 | 1.8 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.4 | 3.2 | GO:0042825 | TAP complex(GO:0042825) |
0.3 | 1.7 | GO:1990462 | omegasome(GO:1990462) |
0.2 | 2.5 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.2 | 1.4 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.2 | 0.7 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.2 | 1.0 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.2 | 1.3 | GO:0033269 | internode region of axon(GO:0033269) |
0.1 | 0.7 | GO:1990037 | Lewy body core(GO:1990037) |
0.1 | 1.1 | GO:0070369 | beta-catenin-TCF7L2 complex(GO:0070369) |
0.1 | 0.6 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.1 | 0.9 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.1 | 2.0 | GO:0043196 | varicosity(GO:0043196) |
0.1 | 0.3 | GO:1990696 | USH2 complex(GO:1990696) |
0.1 | 0.4 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.1 | 1.3 | GO:0033391 | chromatoid body(GO:0033391) |
0.1 | 0.8 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.1 | 0.2 | GO:0042584 | chromaffin granule membrane(GO:0042584) |
0.1 | 0.9 | GO:0042611 | MHC protein complex(GO:0042611) |
0.1 | 0.4 | GO:0071986 | Ragulator complex(GO:0071986) |
0.1 | 0.4 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.1 | 0.6 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.1 | 1.2 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.1 | 1.5 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 0.7 | GO:0043083 | synaptic cleft(GO:0043083) |
0.1 | 0.4 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.0 | 0.7 | GO:0044754 | autolysosome(GO:0044754) |
0.0 | 0.2 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
0.0 | 0.3 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.0 | 0.6 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.0 | 0.3 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.0 | 0.5 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.0 | 2.6 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 0.3 | GO:0030870 | Mre11 complex(GO:0030870) |
0.0 | 0.1 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.0 | 0.2 | GO:0097443 | sorting endosome(GO:0097443) |
0.0 | 1.5 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.0 | 1.0 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.0 | 0.6 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.0 | 0.2 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.0 | 0.4 | GO:0033270 | paranode region of axon(GO:0033270) |
0.0 | 0.1 | GO:1990257 | piccolo-bassoon transport vesicle(GO:1990257) |
0.0 | 1.1 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.0 | 5.3 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.0 | 0.3 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.0 | 0.3 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.0 | 0.5 | GO:0000124 | SAGA complex(GO:0000124) |
0.0 | 0.4 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.0 | 1.3 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.0 | 0.6 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.0 | 0.5 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.0 | 3.0 | GO:0016363 | nuclear matrix(GO:0016363) |
0.0 | 0.3 | GO:0042587 | glycogen granule(GO:0042587) |
0.0 | 3.3 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.0 | 0.2 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.0 | 1.2 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.0 | 0.2 | GO:0002177 | manchette(GO:0002177) |
0.0 | 1.8 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 0.1 | GO:0097165 | nuclear stress granule(GO:0097165) |
0.0 | 0.3 | GO:0097542 | ciliary tip(GO:0097542) |
0.0 | 0.1 | GO:0016939 | kinesin II complex(GO:0016939) |
0.0 | 0.2 | GO:0070695 | FHF complex(GO:0070695) |
0.0 | 0.1 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.0 | 0.4 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.0 | 0.2 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.0 | 0.4 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.0 | 0.2 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.0 | 0.1 | GO:0005861 | troponin complex(GO:0005861) |
0.0 | 0.3 | GO:0005922 | connexon complex(GO:0005922) |
0.0 | 0.1 | GO:0031211 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.0 | 0.1 | GO:0071942 | XPC complex(GO:0071942) |
0.0 | 0.2 | GO:0045179 | apical cortex(GO:0045179) |
0.0 | 0.9 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.0 | 0.2 | GO:0042599 | lamellar body(GO:0042599) |
0.0 | 1.4 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.0 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.0 | 0.1 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 0.1 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.0 | 0.4 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.0 | 0.0 | GO:0043540 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase complex(GO:0043540) |
0.0 | 0.1 | GO:0097441 | basilar dendrite(GO:0097441) |
0.0 | 0.1 | GO:0045293 | mRNA editing complex(GO:0045293) |
0.0 | 3.2 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.0 | 0.2 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.0 | 0.2 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.0 | 0.4 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.0 | 0.6 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.0 | 0.0 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.0 | 0.1 | GO:0001520 | outer dense fiber(GO:0001520) |
0.0 | 1.0 | GO:0036126 | sperm flagellum(GO:0036126) |
0.0 | 0.2 | GO:0031105 | septin complex(GO:0031105) |
0.0 | 0.5 | GO:0031901 | early endosome membrane(GO:0031901) |
0.0 | 0.6 | GO:0005776 | autophagosome(GO:0005776) |
0.0 | 0.1 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.0 | 0.2 | GO:0031527 | filopodium membrane(GO:0031527) |
0.0 | 0.5 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.0 | 0.6 | GO:0010008 | endosome membrane(GO:0010008) |
0.0 | 0.1 | GO:0033503 | HULC complex(GO:0033503) |
0.0 | 0.4 | GO:0031201 | SNARE complex(GO:0031201) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 6.3 | GO:0004556 | alpha-amylase activity(GO:0004556) |
0.7 | 2.0 | GO:0016824 | hydrolase activity, acting on acid halide bonds(GO:0016824) hydrolase activity, acting on acid halide bonds, in C-halide compounds(GO:0019120) alkylhalidase activity(GO:0047651) |
0.6 | 2.8 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.5 | 5.4 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.5 | 3.2 | GO:0046978 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.4 | 0.8 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.4 | 2.3 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
0.4 | 1.1 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.4 | 4.7 | GO:0050700 | CARD domain binding(GO:0050700) |
0.3 | 1.4 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.3 | 0.8 | GO:0050479 | glyceryl-ether monooxygenase activity(GO:0050479) |
0.3 | 1.4 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.2 | 0.7 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.2 | 1.5 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.2 | 1.6 | GO:0016936 | galactoside binding(GO:0016936) |
0.2 | 1.7 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.2 | 1.5 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.2 | 0.9 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
0.2 | 0.5 | GO:0005118 | sevenless binding(GO:0005118) |
0.2 | 0.5 | GO:0070052 | collagen V binding(GO:0070052) |
0.2 | 0.7 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.2 | 1.3 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.1 | 0.4 | GO:0070401 | NADP+ binding(GO:0070401) |
0.1 | 0.6 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.1 | 0.9 | GO:0045340 | mercury ion binding(GO:0045340) |
0.1 | 1.4 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.1 | 1.7 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.1 | 0.1 | GO:1903135 | cupric ion binding(GO:1903135) |
0.1 | 0.8 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.1 | 0.5 | GO:0070976 | TIR domain binding(GO:0070976) |
0.1 | 0.5 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.1 | 1.2 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.1 | 0.4 | GO:0098809 | nitrite reductase activity(GO:0098809) |
0.1 | 0.5 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.1 | 0.5 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
0.1 | 0.3 | GO:0005302 | hydrogen:amino acid symporter activity(GO:0005280) L-tyrosine transmembrane transporter activity(GO:0005302) |
0.1 | 0.4 | GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity(GO:0004483) |
0.1 | 2.7 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.1 | 0.4 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.1 | 1.1 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.1 | 0.7 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
0.1 | 0.3 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.1 | 1.1 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.1 | 0.8 | GO:0031419 | cobalamin binding(GO:0031419) |
0.1 | 0.3 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.1 | 1.3 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.1 | 0.3 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.1 | 0.3 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.1 | 0.3 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) |
0.1 | 0.2 | GO:0036004 | GAF domain binding(GO:0036004) |
0.1 | 0.3 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.1 | 0.2 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.1 | 0.5 | GO:0051430 | corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
0.1 | 0.6 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 0.4 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.1 | 6.2 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.1 | 0.2 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.1 | 2.3 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.1 | 0.6 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.1 | 0.5 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.1 | 0.3 | GO:0003844 | 1,4-alpha-glucan branching enzyme activity(GO:0003844) |
0.1 | 0.4 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.1 | 0.7 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.1 | 0.3 | GO:0089720 | caspase binding(GO:0089720) |
0.1 | 0.2 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.1 | 0.3 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
0.1 | 1.6 | GO:0001848 | complement binding(GO:0001848) |
0.1 | 0.2 | GO:0032129 | histone deacetylase activity (H3-K9 specific)(GO:0032129) NAD-dependent histone deacetylase activity (H3-K9 specific)(GO:0046969) |
0.1 | 1.3 | GO:0070628 | proteasome binding(GO:0070628) |
0.1 | 0.8 | GO:0050308 | sugar-phosphatase activity(GO:0050308) |
0.1 | 1.4 | GO:0005521 | lamin binding(GO:0005521) |
0.1 | 0.9 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.1 | 0.2 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.1 | 0.3 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.1 | 0.2 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.1 | 0.3 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.1 | 1.6 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.0 | 0.2 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.0 | 0.1 | GO:0004619 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.0 | 1.1 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.0 | 0.5 | GO:0043495 | protein anchor(GO:0043495) |
0.0 | 0.2 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.0 | 1.0 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.0 | 0.5 | GO:0070403 | NAD+ binding(GO:0070403) |
0.0 | 0.2 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.0 | 1.8 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.0 | 0.2 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
0.0 | 0.4 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.0 | 0.6 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.0 | 0.1 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.0 | 0.1 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.0 | 2.1 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.0 | 0.1 | GO:0008176 | tRNA (guanine-N7-)-methyltransferase activity(GO:0008176) |
0.0 | 0.1 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.0 | 0.1 | GO:0015526 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.0 | 5.6 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.1 | GO:0005171 | hepatocyte growth factor receptor binding(GO:0005171) |
0.0 | 0.2 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.0 | 0.9 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.0 | 0.1 | GO:0016454 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.0 | 0.4 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.0 | 0.1 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.0 | 0.8 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.0 | 0.4 | GO:0031996 | thioesterase binding(GO:0031996) |
0.0 | 0.3 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.0 | 0.4 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.0 | 0.2 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.0 | 0.2 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.0 | 0.2 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.0 | 0.3 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.0 | 0.1 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.0 | 0.5 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.0 | 0.7 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.0 | 0.2 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.0 | 0.6 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.0 | 0.4 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.0 | 0.2 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
0.0 | 0.2 | GO:0019158 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.0 | 7.2 | GO:0003924 | GTPase activity(GO:0003924) |
0.0 | 1.6 | GO:0019843 | rRNA binding(GO:0019843) |
0.0 | 0.2 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.0 | 1.0 | GO:0050699 | WW domain binding(GO:0050699) |
0.0 | 1.4 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.0 | 0.5 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.0 | 0.3 | GO:0044548 | S100 protein binding(GO:0044548) |
0.0 | 0.1 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.0 | 0.8 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.0 | 0.1 | GO:0003692 | left-handed Z-DNA binding(GO:0003692) double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.0 | 0.1 | GO:1904121 | propanoyl-CoA C-acyltransferase activity(GO:0033814) propionyl-CoA C2-trimethyltridecanoyltransferase activity(GO:0050632) phosphatidylethanolamine transporter activity(GO:1904121) |
0.0 | 0.3 | GO:0098505 | G-rich strand telomeric DNA binding(GO:0098505) |
0.0 | 0.4 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.0 | 0.3 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.0 | 0.1 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.0 | 1.2 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.0 | 0.1 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.0 | 0.6 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.0 | 0.3 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.0 | 1.4 | GO:0043621 | protein self-association(GO:0043621) |
0.0 | 0.1 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.0 | 0.1 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.0 | 0.1 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.0 | 0.1 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
0.0 | 0.2 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.0 | 0.0 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.0 | 0.4 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.0 | 0.5 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.0 | 1.4 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.0 | 0.1 | GO:0005008 | hepatocyte growth factor-activated receptor activity(GO:0005008) |
0.0 | 0.6 | GO:0030552 | cAMP binding(GO:0030552) |
0.0 | 0.2 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.0 | 0.2 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
0.0 | 1.3 | GO:0046906 | heme binding(GO:0020037) tetrapyrrole binding(GO:0046906) |
0.0 | 0.6 | GO:0043531 | ADP binding(GO:0043531) |
0.0 | 0.2 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.0 | 0.1 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.0 | 0.2 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.0 | 0.4 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.0 | 0.1 | GO:0005093 | Rab GDP-dissociation inhibitor activity(GO:0005093) |
0.0 | 0.2 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.0 | 0.1 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.0 | 0.1 | GO:0004661 | protein geranylgeranyltransferase activity(GO:0004661) |
0.0 | 0.2 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.0 | 0.2 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.0 | 0.3 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.0 | 0.3 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.0 | 0.1 | GO:0008494 | translation activator activity(GO:0008494) |
0.0 | 1.2 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.0 | 0.0 | GO:0003884 | D-amino-acid oxidase activity(GO:0003884) |
0.0 | 0.0 | GO:1903136 | cuprous ion binding(GO:1903136) |
0.0 | 0.1 | GO:0016208 | AMP binding(GO:0016208) |
0.0 | 0.1 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.0 | 0.0 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.0 | 0.1 | GO:0022842 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
0.0 | 0.1 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.0 | 0.1 | GO:0051400 | BH domain binding(GO:0051400) |
0.0 | 0.3 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 2.6 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.1 | 1.8 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 1.6 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 0.8 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.1 | 5.0 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.1 | 2.0 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 0.5 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 1.9 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.1 | 0.6 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.1 | 1.3 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 3.3 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.0 | 0.6 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.0 | 1.1 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.0 | 1.1 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.0 | 0.4 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.0 | 2.0 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.0 | 0.6 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.2 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.0 | 0.4 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.0 | 0.4 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 0.3 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.0 | 0.7 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.0 | 0.5 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.0 | 0.8 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 0.3 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.0 | 0.4 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 1.1 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 0.4 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 2.0 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.0 | 0.6 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.0 | 0.6 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 0.2 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.0 | 0.0 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.0 | 0.4 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.0 | 3.3 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 2.5 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.4 | PID ARF6 PATHWAY | Arf6 signaling events |
0.0 | 0.2 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.0 | 0.3 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.0 | 0.5 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.0 | 0.1 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.0 | 0.4 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 0.4 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 0.2 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.0 | 0.4 | PID ENDOTHELIN PATHWAY | Endothelins |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 1.6 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.3 | 6.0 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.3 | 15.0 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.2 | 1.8 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.1 | 1.9 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.1 | 1.5 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.1 | 1.4 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.1 | 1.4 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 1.1 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.1 | 2.2 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.1 | 1.6 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.1 | 1.6 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.1 | 1.1 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.1 | 0.5 | REACTOME DEFENSINS | Genes involved in Defensins |
0.1 | 0.1 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.0 | 0.3 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.0 | 0.9 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.0 | 0.3 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.0 | 0.7 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.0 | 0.3 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.0 | 1.5 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.0 | 1.6 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.0 | 0.6 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.0 | 1.4 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.0 | 0.8 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.0 | 0.9 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.0 | 0.5 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.0 | 0.9 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 1.0 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.0 | 0.3 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.0 | 1.2 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.0 | 1.2 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.0 | 0.9 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.0 | 0.5 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.0 | 0.6 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.0 | 0.3 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.0 | 0.4 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.0 | 1.1 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 0.2 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.0 | 0.2 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.0 | 1.0 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 1.1 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 0.2 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.0 | 0.2 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.0 | 0.2 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.0 | 0.2 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.0 | 0.2 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.0 | 0.6 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.0 | 0.3 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.0 | 0.3 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.0 | 0.1 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.0 | 0.4 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.0 | 0.4 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 0.3 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.0 | 0.5 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.0 | 0.7 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 0.3 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.0 | 0.3 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.0 | 1.1 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.0 | 0.9 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.0 | 0.1 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.0 | 0.2 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.0 | 0.1 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.0 | 0.5 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.0 | 0.1 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.0 | 0.5 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.0 | 0.5 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 0.2 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.0 | 0.2 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |